High-dose induction chemoradiotherapy followed by autologous bone marrow transplantation as consolidation therapy in rhabdomyosarcoma, extraosseous Ewing's sarcoma, and undifferentiated sarcoma

Journal of Clinical Oncology

Volumn 16, Issue 5, 1998, Pages 1697-1706

  Boulad, F ^a   Kernan, N A ^a   LaQuaglia, M P ^a   Heller, G ^a   Lindsley, K L ^a   Rosenfield, N S ^a   Abramson, S J ^a   Gerald, W L ^a   Small, T N ^a   Gillio, A P ^a   Gulati, S C ^a   O'Reilly, R J ^a   Ghavimi, F ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; MELPHALAN; MESNA; VINCRISTINE;

ADOLESCENT; ADULT; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CHILD; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; DRUG MEGADOSE; EWING SARCOMA; FEMALE; FEVER; GASTROINTESTINAL TOXICITY; HEMATOLOGIC DISEASE; HEMORRHAGIC CYSTITIS; HUMAN; INFECTION; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RADIATION INJURY; RHABDOMYOSARCOMA; SARCOMA; SKIN TOXICITY; STOMATITIS;

EID: 0031833516     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1998.16.5.1697     Document Type: Article

References (55)

1. Crist W, Gehan E, Ragab A, et al.: The Third Intergroup Rhabdomyosarcoma Study. J Clin Oncol 13:610-630, 1995
2. Cheung N, Heller G: Chemotherapy dose intensity correlates strongly with response, median survival, and median progression-free survival in metastatic neuroblastoma. J Clin Oncol 9:1050-1058,1991
3. Kushner B, Meyers P, Cheung N, et al.: Very high-dose short-term chemotherapy for poor-risk solid tumors in children and young adults. Proc Am Soc Clin Oncol 12:413, 1993 (abstr 1416)
4. Kushner B, LaQuaglia M, Bonilla M, et al.: Highly effective induction therapy for stage 4 neuroblastoma in children over 1 year of age. J Clin Oncol 12:2607-2613, 1994
5. Graham-Pole J, Casper J, Elfenbein G, et al.: High-dose chemoradiotherapy supported by marrow infusions for advanced neuroblastoma: APediatric Oncology Group study. J Clin Oncol 9:152-158, 1991
6. McElwain TJ, Hedley DW, Gordon MY: High dose melphalan and non-cryopreserved autologous bone marrow treatment of malignant melanoma and neuroblastoma. Exp Hematol 7:360-371, 1979
7. Philip T, Zucker J, Bernard J, et al.: Improved survival at 2 and 5 years in the LMCE1 unselected group of 72 children with stage IV neuroblastoma older than 1 year of age at diagnosis: Is cure possible in a small subgroup? J Clin Oncol 9:1037-1044,1991
8. Pinkerton R, Philip T, Bouffet E, et al.: Autologous bone marrow transplantation in pédiatrie solid tumours. Clin Haematol 15:187-203, 1986
9. Pinkerton CR: Megatherapy for soft tissue sarcomas. EBMT experience. Bone Marrow Transplant 7:120-122,1991
10. Lanino E, Garaventa A, Miniero R, et al.: High-dose cisplatin plus VP-16, ablative therapy and autologous bone marrow rescue in relapsed and resistant Wilms tumour, in Dicke K, Spitzer G, Jagannath S, et al. (eds): Proceedings of the Fourth International Symposium of ABMT. Houston, TX, University of Texas, 1987, pp 221-225
11. Tsokos M, Webber BL, Parham DM, et al.: Rhabdomyosarcoma: A new classification scheme related to prognosis. Arch Pathol Lab Med 116:847-855,1992
12. Harmer M: TNM Classification of Pédiatrie Tumours. Geneva, Switzerland, International Union Against Cancer, 1982
13. Gulati S, Shank B, Black P, et al.: Autologous bone marrow transplantation for patients with poor-prognosis lymphoma. J Clin Oncol 6:1303-1313,1988
14. Kaplan E, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481,1958
15. Ghavimi F, Exelby P, D'Angio G, et al.: Multidisciplinary treatment of embryonal rhabdomyosarcoma in children. Cancer 35:667-686,1975
16. Ghavimi F, Exelby PR, Jereb B, et al.: Multidisciplinary treatment of advanced stages of embryonal rhabdomyosarcoma in children. NCIMonogr 56:103-109,1981
17. Ozkaynak MF, Nolta J, Parkman R: In vitro purging of human rhabdomyosarcoma cells using 4-hydroperoxycyclophosphamide. Cancer Res 50:1455-1458, 1990
18. Nemunaitis J, Buckner D, Appelbaum F, et al.: Phase I/trial of recombinant human granulocyte-macrophage colony-stimulating factor following allogeneic bone marrow transplantation. Blood 77:2056-2071,1991
19. Maurer HM, Beltangady M, Gehan EA, et al.: The Intergroup Rhabdomyosarcoma Study I: A final report. Cancer 61:209-220, 1988
20. Maurer HM, Gehan EA, Beltangady M, et al.: The Intergroup Rhabdomyosarcoma Study-II. Cancer 71:1904-1922, 1993
21. Crist W, Raney BR, Newton W, et al.: Intrathoracic soft tissue sarcomas in children. Cancer 50:598-604, 1982
22. Crist WM, Raney BR, Tefft M, et al.: Soft tissue sarcomas arising in the retroperitoneal space in children: A report from the Intergroup Rhabdomyosarcoma Study (1RS) Committee. Cancer 56:2125-2132, 1985
23. Crist WM, Garnsey L, Beltangady MS, et al.: Prognosis in children with rhabdomyosarcoma: A report of the Intergroup Rhabdomyosarcoma Studies I and II. J Clin Oncol 8:443-452,1990
24. Onega J, Wharam M, Gehan E, et al.: Clinical features and results of therapy for children with paraspinal soft tissue sarcoma: A report of the Intergroup Rhabdomyosarcoma Study. J Clin Oncol 9:796-801, 1991
25. Raney RB, Crist W, Hays D, et al.: Soft tissue sarcoma of the perineal region in childhood. Cancer 65:2787-2792, 1990
26. Miser J, Kinsella TJ, Triche TJ, et al.: Ifosfamide with mesna uroprotection and etoposide: an effective regimen in the treatment of recurrent sarcomas and other tumors of children and young adults. J Clin Oncol 5:1191-1198,1987
27. Kung F, Pratt C, Vega R, et al.: Ifosfamide/etoposide combination in the treatment of recurrent malignant solid tumors of childhood. Cancer71:1898-1903, 1992
28. Ghavimi F, Cahill J, Cacavio A, et al.: Continuous infusion of high dose ifosfamide, mesna and etoposide in patients with high risk rhabdomyosarcoma, undifferentiated sarcoma or extraosseous Ewing's sarcoma. Proc Am Soc Clin Oncol 12:417,1993 (abstr 1430)
29. Tan C, Rosen G, Ghavimi F, et al.: Adriamycin (NSC 123127) in pédiatrie malignancies. Cancer Chemother Rep 6:259-266, 1975
30. Legha SS, Benjamin RS, Mackay B, et al.: Reduction of doxorubicin cardiotoxicity by prolonged continuous intravenous infusion. Ann Intern Med 96:133-139, 1982
31. Houghton JA, Williams LG, Torrance PM, etal: Determinants of intrinsic sensitivity to vinca alkaloids in xenografts of pédiatrie rhabdomyosarcomas. Cancer Res 44:582-590, 1984
32. Jereb B, Ghavimi F, Chain W, et al.: Local control of embryonal rhabdomyosarcoma in children by radiation therapy. Int J Radiât Oncol BiolPhys 1:217-225, 1976
33. Jereb B, Ghavimi F, Exelby P, et al.: Local control of embryonal rhabdomyosarcoma in children by radiation therapy when combined with chemotherapy. Int J Radiât Oncol Biol Phys 6:827-833, 1980
34. Mandell L, Ghavimi F, Exelby P, et al.: Preliminary results of alternating combination chemotherapy (CT) and hyperfractionated radiotherapy (HART) in advanced rhabdomyosarcoma. Int J Radiât Oncol Biol Phys 15:197-203, 1988
35. Houghton JA, Cook RL, Lutz PJ, et al.: Melphalan: A potential new agent in the treatment of childhood rhabdomyosarcoma. Cancer Treat Rep 69:91-96,1985
36. HorowitJ. M, Etcubanas E, Christesed M, et al.: Phase testing of melphalan in children with newly diagnosed rhabdomyosarcoma: A model for anticancer drug development. J Clin Oncol 6:303-314, 1988
37. Lilley ER, Rosenberg MC, Elion GB, et al.: Synergistic interactions between cyclophosphamide or melphalan and VP-16 in a human rhabdomyosarcoma xenograft. Cancer Res 50:284-287, 1990
38. Horowitz ME, Kinsella TJ, Kinsella LH, et al.: Total-body irradiation and autologous bone marrow transplant in the treatment of high-risk Ewing's sarcoma and rhabdomyosarcoma. J Clin Oncol 11:1911-1918,1993
39. Pritchard J, McEhvain TJ, Graham-Pole J: High dose melphalan with autologous marrow for treatment of advanced neuroblastoma. Br J Cancer 45:89-94,1982
40. Postmus PE, Mulder NH, Sleijfer DT, et al.: High-dose etoposide for refractory malignancies: A phase I study. Cancer Treat Rep 68:1471-1474,1984
41. Wolff S, Johnson DH, Hainsworth JD, et al.: High-dose VP-16-213 monotherapy for refractory germinal malignancies: A phase study. J Clin Oncol 2:271-274, 1984
42. Bostrom B, Alvarez O, Ghavimi F, et al.: High-dose continuous infusion etoposide without bone marrow rescue: A phase II/II1 study in children. J Clin Oncol (submitted)
43. Santana V, Schell M, Williams R, et al.: Escalating sequential high-dose carboplatin and etoposide with autologous marrow support in children with relapsed solid tumors. Bone Marrow Transplant 10:457-462, 1992
44. Pinkerton CR, Groot-Loonen J, Barren A, et al.: Rapid VAC, high dose melphalan regimen. A novel chemotherapy approach for childhood soft tissue sarcomas. BrJ Cancer 64:381-385,1991
45. Koscielniak E, Klingebiel TH, Peters C, et al.: Do patients with metastatic or recurrent rhabdomyosarcoma benefit from high dose therapy with hematopoietic rescue? Report of the German/Austrian Pédiatrie Bone Marrow Transplantation Group. Bone Marrow Transplant 19:227-231, 1997
46. deKraker J, Voûte PA: Experience with ifosfamide in pédiatrie tumors. Cancer Chemother Pharmacol 24:S28-S29, 1989
47. Ortega J, Ragab A, Gehan E, et al.: Ifosfamide (IF), actinomycin-D (AD), and vincristine (VCR) for the treatment of childhood rhabdomyosarcoma (RMS): A feasibility and toxicity study. A report for the Intergroup Rhabdomyosarcoma Study. Proc Am Soc Clin Oncol 10:314,1991 (abstril02)
48. Raney RB, Crist WM, Donaldson SS, et al.: A pilot study of ifosfamide/mesna and doxorubicin followed by vincristine, actinomycin D, cyclophosphamide and hyperfractionated irradiation for children with metastatic soft-tissue sarcoma: A report from the Intergroup Rhabdomyosarcoma Study (1RS). Proc Am Soc Clin Oncol 10:313, 1991 (abstr 1098)
49. Levin L, Hryniuk WM: Dose intensity analysis of chemotherapy regimens in ovarian carcinoma. J Clin Oncol 5:756-767, 1987
50. Tefft M, Wharam M, Gehan E: Local and regional control by radiation of rhabdomyosarcoma in 1RS II. Med Pediatr Oncol 16:415, 1988
51. Regine W, Fontanesi J, Kumar P, et al.: Phase trial evaluating selective use of altered radiation dose and fractionation in patients with unresectable rhabdomyosarcoma. Int J Radiât Oncol Biol Phys 31:799-805,1995
52. Rill DR, Santana VM, Roberts WM, et al.: Direct demonstration that autologous bone marrow transplantation for solid tumors can return a multiplicity of tumorigenic cells. Blood 84:380-383, 1994
53. Barr F, Galili N, Holick J, et al.: Rearrangement of the PAX3 paired box gene in the paediatric solid tumour alveolar rhabdomyosarcoma. Nature3:113-117, 1993
54. Moss TJ, Cairo M, Santana VM, et al.: Clonogenicity of circulating neuroblastoma cells: Implications regarding peripheral blood stem cell transplantation. Blood 83:3085-3089, 1994
55. Dominici C, Deb G, Angioni A, et al.: Peripheral blood stem cells in children with solid tumors. Part II. Immunocytologic detection of tumor cells in bone marrow and peripheral blood stem cell harvests. Anticancer Res 13:2573-2576,1993